Which of the Following Is an Example of an Erythropoiesis-stimulating Agent (ESA) Used in the Treatment of Anemia

Mr. Santos, a 65-year-old Male, Is Admitted to the Hospital with a Diagnosis of Chronic Kidney Disease. He Has Been Experiencing Fatigue, Weakness and Shortness of Breath. Laboratory Results Reveal a Low Red Blood Cell Count and Hemoglobin Level. the Healthcare Provider Suspects Anemia and Plans to Initiate Treatment